Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
N.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
N.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
N.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
N.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
N.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
N.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BV.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CP.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CP.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CP.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used